StonvexLoading…
StonvexCore line items from EVC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $196.97M | $447.59M | $313.22M | $192.59M |
Operating Income | $20.69M | $-83.36M | $-62.70M | $-53.62M |
Net Income | $12.36M | $-79.17M | $-60.96M | $-51.30M |
EPS (Diluted) | $0.13 | $-0.87 | $-0.67 | $-0.56 |
Total Assets | $436.39M | $387.51M | $414.60M | $418.00M |
Total Liabilities | $371.43M | $332.07M | $336.44M | $327.99M |
Cash & Equivalents | $68.17M | $59.44M | $61.76M | $64.51M |
Free Cash Flow OCF − CapEx | $18.15M | $3.51M | $-5.16M | $-12.22M |
Shares Outstanding | 96.42M | 91.02M | 90.98M | 90.98M |